Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

JAMA Health Forum

2025-10-17

(Press-News.org) About The Study: This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain. However, further research directly observing cannabis use is needed to evaluate the efficacy of cannabis as a treatment for cancer-related pain.

Corresponding Author: To contact the corresponding author, Victoria Bethel, MSN, email vbethel@uga.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2025.3512)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.3512?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=101725

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

END

ELSE PRESS RELEASES FROM THIS DATE:

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

2025-10-17

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, “The Gain-of-Function TREM2-T96K Mutation Increases Risk for Alzheimer’s Disease by Impairing Microglial Function.” Q: How would you summarize your study for a lay audience? Our team wanted to understand how immune cells of the brain, called microglia, contribute to Alzheimer’s disease (AD) pathology. It’s known that subtle changes, or mutations, in genes expressed in microglia are associated with an increased ...

Missing molecule may explain Down syndrome

2025-10-17

Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the nervous system, new research suggests. Restoring the molecule, called pleiotrophin, could improve brain function in Down syndrome and other neurological diseases – possibly even in adults, the researchers say. The scientists conducted their work in lab mice, rather than in people, so the approach is far from being available as a treatment. But the researchers found that administering pleiotrophin improved brain function in adult ...

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

2025-10-17

About The Study: The 1-year success rate in eyes undergoing Descemet membrane endothelial keratoplasty (DMEK) with successfully prepared tissue was very high regardless of donor diabetes status. These results, supported by the separately reported finding that endothelial cell loss and cornea morphometry after 1 year were not affected by donor diabetes status, provide strong support for having no restrictions on the use of tissue from donors with diabetes for DMEK. Corresponding Author: To contact the corresponding author, Jonathan H. Lass, MD, email deks@case.edu. To access the embargoed study: Visit our For The Media website at this link ...

Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study

2025-10-17

About The Study: This randomized clinical trial found that endothelial cell loss and morphometry 1 year after Descemet membrane endothelial keratoplasty (DMEK) were not affected by cornea donor diabetes status. With comparable 1-year graft success with tissue from donors with and without diabetes demonstrated in this trial, these findings support the use of corneas from donors with diabetes for endothelial keratoplasty procedures. Corresponding Author: To contact the corresponding author, Jonathan ...

Overactive Runx1 gene triggers early disc degeneration linked to aging

2025-10-17

“Taken together, these findings reveal a novel role of Runx1 in maintaining disc health and regulating age-related degenerative processes.” BUFFALO, NY — October 17, 2025 — A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, “Runx1 overexpression induces early onset of intervertebral disc degeneration.” In this study, led by first author Takanori Fukunaga from Emory University School of Medicine and corresponding author Hicham Drissi from Emory and the Atlanta VA Medical Center, researchers found that the Runx1 gene, when overactive in spinal disc cells, ...

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

2025-10-17

ORLANDO, FLORIDA, OCTOBER 17, 2025—NYU Langone Health ophthalmology faculty present their latest research at this year’s annual meeting of the American Academy of Ophthalmology (AAO), where Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor and chair of the Department of Ophthalmology at NYU Grossman School of Medicine, will be awarded the prestigious Castroviejo Medal from the Cornea Society. This honor recognizes Dr. Colby’s groundbreaking contributions to the field of ophthalmology, particularly in the promotion, research, and understanding of the cornea. Among the presentations at AAO in Orlando, October 17 ...

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

2025-10-17

BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib alone. The finding is based on an analysis of the complete data from the phase 3 global FLAURA2 study, co-led by researchers from Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France). Median overall survival was 47.5 months in the osimertinib plus platinum–pemetrexed group versus 37.6 months ...

FAU’s Queen Conch Lab receives prestigious international award

2025-10-17

The Florida Atlantic University Harbor Branch Oceanographic Institute’s Queen Conch Lab, led by research professor Megan Davis, Ph.D., has been named the recipient of the 2025 Responsible Seafood Innovation Award in Aquaculture from the Global Seafood Alliance (GSA). The award honors the Queen Conch Lab’s development of mobile lab hatcheries designed to help restore the threatened Caribbean queen conch. These self-contained, trailer-based hatcheries bring advanced aquaculture capabilities to coastal communities across the Caribbean, many of which lack traditional infrastructure. This innovation is not only helping to rebuild wild ...

Post-traumatic vasospasm: An overlooked threat after brain injury

2025-10-17

A new review published in the Journal of Intensive Medicine on 25 July, 2025 and led by Dr. Alice Jacquens and Dr. Clara Perrault from Pitié Salpêtrière Hospital, Paris, France, sheds light on an under-recognized complication of traumatic brain injury (TBI): post-traumatic vasospasm (PTV). PTV is a sudden narrowing of brain arteries that can lead to stroke and long-term neurological damage. It may affect up to 60% of TBI patients but is often missed, especially in intensive care units where ...

Scientists smash record in stacking semiconductor transistors for large-area electronics

2025-10-17

King Abdullah University of Science and Technology (KAUST; Saudi Arabia) researchers have set a record in microchip design, achieving the first six-stack hybrid CMOS (complementary metal-oxide semiconductor) for large-area electronics. With no other reported hybrid CMOS exceeding two stacks, the feat marks a new benchmark in integration density and efficiency, opening possibilities in electronic miniaturization and performance. Among microchip technologies, CMOS microchips are found in nearly all electronics, from phones and televisions to satellites and medical devices. Compared with conventional silicon chips, hybrid CMOS microchips hold greater promise ...

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: